|
⚲
|
| Keyboard |
| Charles Homcy | |
|---|---|
| Firm | |
| Address | 215 First Street, Suite 440 Cambridge, MA 02142 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| FAZE Medicines Inc | 021-384105 | Director | 30.4 M of 81.0 M |
||
| Pliant Therapeutics Inc | 021-357505 | Director | 100.4 M of 100.4 M |
||
| Pliant Therapeutics Inc | 021-317423 | Director | of 62.1 M |
||
| Myokardia Inc | 021-238915 | Director | 46.0 M of 46.0 M |
||
| Myokardia Inc | 021-223478 | Director | 10.0 M of 10.0 M |
||
| Myokardia Inc | 021-184969 | Executive Officer | 0.0 M of 0.0 M |
||
| Myokardia Inc | 021-184968 | Executive Officer | 4.0 M of 38.0 M |
||
| CytomX Therapeutics Inc | 021-182499 | Director | 12.6 M of 26.0 M |
||
| Myokardia Inc | 021-180721 | Executive Officer | 0.0 M of 0.0 M |
||
| Portola Pharmaceuticals Inc | 021-170477 | Director | 9.0 M of 9.0 M |
||
| Portola Pharmaceuticals Inc | 021-169528 | Director | 89.0 M of 90.0 M |
||
| Portola Pharmaceuticals Inc | 021-59981 | Executive Officer | 60.1 M of 60.1 M |
||